Delivery Order SPE2DR25D2101-SPE2DR26F46DM
- Not listed
- The Defense Logistics Agency awarded a $4,971.89 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The non-set-aside, firm fixed price contract is a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This prime contract vehicle supports comprehensive pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a $12,072.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-competitive delivery order, which is set to be completed by November 18, 2025, represents a routine pharmaceutical procurement for the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense...
- The Defense Logistics Agency awarded a $41,766.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), carries an ultimate completion date of August 22, 2025. This award was competitively granted with no...
- The Defense Logistics Agency awarded a $7,121.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of July 15, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $33,388.01 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance completion by December 2, 2025. This non-set-aside, firm fixed-price delivery order was issued on December 1, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $89,390.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract is unclassified and non-set-aside, with an ultimate completion date of November 12, 2025. As a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), this award leverages...
- The Defense Logistics Agency awarded a $22,429.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied to the place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $2,473.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 21, 2025. This non-set-aside competitive award was issued on October 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $8,343.74 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector medication, with performance completion scheduled for December 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.53 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pharmaceutical products. This firm fixed price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46DMDelivery Order
The Defense Logistics Agency awarded a $4,667.05 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of December 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's comprehensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies through competitive awards with the Defense Logistics Agency. This delivery order for Repatha, a specialty cardiovascular medication, exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible and extensive contract vehicles designed to meet military medical supply needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 12/2/25 |